The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.
Mar 1, 2023
0
14
Two Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China's National Medical Products Administration (NMPA) in late ...
Feb 7, 2023
0
18
Some 30,000 people in the U.S. are affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative condition that damages cells in the brain and spinal cord necessary for movement.
Feb 4, 2023
0
132
If pharmaceutical companies shared their intellectual property rights to vaccines with the global community, millions of lives could be saved in future pandemics, according to a new paper co-authored by faculty at Binghamton ...
Jan 18, 2023
0
15
Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.
Jan 11, 2023
0
5
Technology that reliably kills airborne viruses inside buildings could prevent most cases of cold and flu and might have saved millions of lives during the COVID-19 pandemic, according to a Rutgers expert.
Nov 9, 2022
0
61
After decades of research and two previous drug development attempts, things are looking promising for a team of University of Arizona researchers working on a less toxic treatment for a specific type of breast cancer.
Oct 25, 2022
0
94
Inequitable access to COVID-19 vaccines has turned out to be the catastrophic moral failure the World Health Organization's director-general warned about at the beginning of 2021.
Aug 30, 2022
0
13
Maggie Carmichael wasn't developing like other kids. As a toddler, she wasn't walking and had a limited vocabulary for her age.
Jul 26, 2022
0
8
Researchers have called for an experimental COVID treatment, which has shown early indications of being more effective against dominant Omicron subvariants, to be made available outside the United States.
Jul 22, 2022
0
14
